This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Penmix Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Joo Hwan Kim: Innovator in Lipolytic Composition
Introduction
Joo Hwan Kim is a notable inventor based in Siheung, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of obesity treatment. His innovative work focuses on developing effective solutions for lipolysis.
Latest Patents
Joo Hwan Kim holds 1 patent for his invention titled "Lipolytic composition containing phosphocholine derivatives." This patent presents a composition designed for lipolysis, which includes a pharmaceutical formulation aimed at preventing or treating obesity, especially concerning localized fat deposits. The composition comprises specific phosphocholine derivatives or their pharmaceutically acceptable salts. Notably, this pharmaceutical composition demonstrates excellent lipolytic activity and uniformity, while also minimizing potential side effects such as inflammation and tissue necrosis at the site of administration. Furthermore, it boasts remarkable storage stability.
Career Highlights
Joo Hwan Kim is associated with Penmix Ltd., where he continues to advance his research and development efforts. His work is pivotal in creating innovative solutions that address pressing health issues related to obesity.
Collaborations
Some of his coworkers include Young Sub Song and Ji Hyun Moon, who contribute to the collaborative efforts at Penmix Ltd. Their teamwork enhances the research environment and fosters innovation.
Conclusion
Joo Hwan Kim's contributions to the field of lipolytic compositions highlight his commitment to addressing obesity through innovative pharmaceutical solutions. His work exemplifies the impact of dedicated inventors in the health sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile